Advances in Treating HER2-Mutant Lung Cancer: Efficacy Podcast Por  arte de portada

Advances in Treating HER2-Mutant Lung Cancer: Efficacy

Advances in Treating HER2-Mutant Lung Cancer: Efficacy

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

Stephen V. Liu, MD and Susan C. Scott, MD discuss advances in treating HER2-mutant lung cancer. Until recently, treatments for HER2-mutant lung cancer primarily involved chemotherapy, immunotherapy, and HER2-targeted therapies, with mixed results. Now, the treatment landscape of HER2-mutant lung cancer is changing.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones